Myeloma patients move to Australia for cancer drug not funded here
“I was quite accepting, thinking that the medics all knew what they were talking about. But they’re only…
Genomic clues uncover early origins of multiple myeloma
A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood…
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
Maura, F. et al. Moving from cancer burden to cancer genomics for smoldering myeloma: a review. JAMA Oncol.…